Literature DB >> 6201996

Correlation between serum concentrations of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations.

A Borgström, L Wehlin.   

Abstract

The concentrations of pancreatic amylase, immunoreactive trypsin, and immunoreactive pancreatic specific trypsin inhibitor have been studied in serum drawn from 258 patients before an endoscopic retrograde cholangiopancreatography (ERCP) examination, in which both ducts were successfully filled. The results are correlated to the morphology of the ducts and the diagnosis given at the ERCP examination. One third of the patients with normal morphology of both ducts showed an abnormal concentration of at least one of the measured specific pancreatic proteins. Sixteen out of 38 patients with changes suggestive of chronic pancreatitis and 6 out of 23 patients with changes suggestive of pancreatic cancer showed normal levels of all variables measured. The sensitivity and specificity for pancreatic disease evident by ERCP were around 0.40 and 0.80, respectively, for all three proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201996

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Severe acute pancreatitis and normal serum amylase activity due to pancreatic isoamylase deficiency.

Authors:  A Borgström; M Bohe
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

3.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

4.  Selective deficiency of pancreatic amylase.

Authors:  K Sjölund; A Häggmark; I Ihse; G Skude; U Kärnström; M Wikander
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

5.  Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.

Authors:  A Borgström; A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1995-12

6.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Quantification of pancreatic secretory trypsin inhibitor in colonic carcinoma and normal adjacent colonic mucosa.

Authors:  H Bohe; M Bohe; P Jönsson; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 8.  Pancreatic function testing: here to stay for the 21st century.

Authors:  John G Lieb; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

9.  Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis.

Authors:  Hyoung-Chul Oh; Chang-Il Kwon; Ihab I El Hajj; Jeffrey J Easler; James Watkins; Evan L Fogel; Lee McHenry; Stuart Sherman; Michelle K Zimmerman; Glen A Lehman
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

Review 10.  Chronic pancreatitis: review and update of etiology, risk factors, and management.

Authors:  Angela Pham; Christopher Forsmark
Journal:  F1000Res       Date:  2018-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.